Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | FDPS | P14324 | 1/20 | 0.33 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.32 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.32 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.32 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL571523 | 0.91 | TSHR (0.44) | TSHRTHRBFDPS | |
| SCHEMBL1101547 | 0.90 | TSHR (0.41) | TSHRLMNATHRBFDPS | |
| SCHEMBL30381193 | 0.88 | TSHR (0.47) | TSHRTHRBFDPS | |
| SCHEMBL7189663 | 0.88 | TSHR (0.47) | TSHRTHRBFDPS | |
| SCHEMBL8470352 | 0.88 | TSHR (0.47) | TSHRTHRBFDPS | |
| SCHEMBL28571235 | 0.88 | TSHR (0.47) | TSHRTHRBFDPS | |
| SCHEMBL11757198 | 0.85 | TSHR (0.32) | TSHRLMNATHRBFDPS | |
| SCHEMBL571531 | 0.83 | TSHR (0.42) | TSHRTHRBFDPS | |
| SCHEMBL28728010 | 0.83 | TSHR (0.42) | TSHRTHRBFDPS | |
| SCHEMBL8663555 | 0.81 | TSHR (0.40) | TSHRTHRBFDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 132 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4000636-B1 | SUBSTANCES CONTAINING AUCS AND PREPARATION METHOD AND USE THEREOF | SHENZHEN PROFOUND VIEW PHARMA TECH CO LTD (CN) | 2025-09-03 | — | — | EP | claimed |
| WO-2024207829-A1 | LIGHT CONVERSION FILM COMPOSITION, LIGHT CONVERSION FILM, AND PHOTOVOLTAIC MODULE | 杭州福斯特应用材料股份有限公司 | 2024-10-10 | — | — | WO | claimed |
| EP-4313350-A1 | PROCESS FOR ISOLATION AND/OR PURIFYING OF GLYCOLIPIDS | AMPHISTAR BV (BE) | 2024-02-07 | — | — | EP | claimed |
| CN-112675196-B | Compositions and methods for treating diabetes | 深圳深见医药科技有限公司 | 2023-05-16 | — | — | CN | claimed |
| WO-2022207086-A1 | PROCESS FOR ISOLATION AND/OR PURIFYING OF GLYCOLIPIDS | BIO BASE EUROPE PILOT PLANT VZW (BE) | 2022-10-06 | — | — | WO | claimed |
| EP-3545948-B1 | USE OF GOLD CLUSTER OR GOLD CLUSTER-CONTAINING SUBSTANCE IN PREPARATION OF DRUG FOR PREVENTING AND/OR TREATING GLAUCOMA | SHENZHEN PROFOUND VIEW PHARMA TECH CO LTD (CN) | 2021-08-11 | — | — | EP | claimed |
| CN-112675196-A | Compositions and methods for treating diabetes | 深圳深见医药科技有限公司 | 2021-04-20 | — | — | CN | claimed |
| EP-2651828-B1 | PROCESS FOR PREPARING A COMPOSTION OF MIXED PARTICLES CONTAINING ELEMENTS FROM COLUMNS 13 AND 15 | CENTRE NAT RECH SCIENT (FR) | 2015-02-11 | — | — | EP | claimed |
| EP-2651828-A1 | PROCESS FOR PREPARING A COMPOSTION OF MIXED PARTICLES CONTAINING ELEMENTS FROM COLUMNS 13 AND 15 | Centre National De La Recherche Scientifique CNRS (FR) | 2013-10-23 | — | — | EP | claimed |
| WO-2012080425-A1 | PROCESS FOR PREPARING A COMPOSTION OF MIXED PARTICLES CONTAINING ELEMENTS FROM COLUMNS 13 AND 15 | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) | 2012-06-21 | — | — | WO | claimed |
| EP-1167300-B1 | Photodegradative process for the purification of contaminated water | ENITECNOLOGIE SPA (IT) | 2004-08-04 | — | — | EP | claimed |
| US-20020030021-A1 | Photodegradative process for the purification of contaminated water | ENITECNOLOGIE S.P.A. (IT) | 2002-03-14 | — | — | US | claimed |
| EP-1167300-A1 | Photodegradative process for the purification of contaminated water | Enitechnologie S.p.A. (IT) | 2002-01-02 | — | — | EP | claimed |
| US-6126993-A | Coating compositions for optical fibers, and a method of coating optical fibers | ALCATEL (FR) | 2000-10-03 | — | — | US | claimed |
| EP-0166026-A2 | Process for the preparation of N-thiocarboxyanhydrides of amino acids | CHEMI S.p.A. (IT) | 1986-01-02 | — | — | EP | claimed |
| EP-4746852-A1 | LIPID AGGREGATES FOR INTRAARTICULAR ADMINISTRATION | Universität Bern (CH) | 2026-05-27 | — | — | EP | disclosed |
| US-20260042795-A1 | DIPROPYLAMINE AS BASE FOR THE USE IN FMOC DEPROTECTION IN SOLID-PHASE PEPTIDE SYNTHESIS | Universität Bern (CH) | 2026-02-12 | — | — | US | disclosed |
| EP-0166026-A3 | PROCESS FOR THE PREPARATION OF N-THIOCARBOXYANHYDRIDES OF AMINO ACIDS | CHEMI S.p.A. (IT) | 1986-09-03 | — | — | EP | disclosed |
| EP-0166026-A2 | Process for the preparation of N-thiocarboxyanhydrides of amino acids | CHEMI S.p.A. (IT) | 1986-01-02 | — | — | EP | disclosed |
| EP-0166026-A2 | Process for the preparation of N-thiocarboxyanhydrides of amino acids | CHEMI S.p.A. (IT) | 1986-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260042795-A1 | DIPROPYLAMINE AS BASE FOR THE USE IN FMOC DEPROTECTION IN SOLID-PHASE PEPTIDE SYNTHESIS | PTMS, PEPD, ASNS | TSHR 2161/4885LMNA 2408/4885THRB 2327/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.